The AASM guidelines state that psychological and behavioral interventions are effective and recommended for chronic insomnia, both primary and secondary types. Initial approaches to treatment should include at least one behavioral intervention, such as stimulus control therapy; relaxation therapy; or a combination of cognitive therapy, stimulus control therapy, and sleep restriction therapy with or without relaxation therapy. The AASM guidelines also state that over-the-counter antihistamines, antihistamine/analgesic drugs, barbiturates, barbiturate-type drugs, and chloral hydrate are not recommended for the treatment of chronic insomnia.
According to the AASM guidelines, polysomnography and daytime MSLT are not indicated in the routine assessment of chronic insomnia, including insomnia due to neuropsychiatric or psychiatric disorders. Polysomnography is indicated when sleep apnea or movement disorders are suspected, as well as when initial diagnosis is unclear, treatment fails, or precipitous arousals occur with violent or injurious behavior.
Medscape © 2019 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: George D. Harris. Fast Five Quiz: Stress-Related Conditions - Medscape - Sep 26, 2019.